These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 29580639)

  • 1. Official batch control of influenza vaccines: Is it still useful?
    Kretzschmar E; Muckenfuss H; Pfleiderer M
    Vaccine; 2018 Apr; 36(17):2364-2370. PubMed ID: 29580639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The network of official medicines control laboratories].
    Buchheit KH; Wanko R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Oct; 57(10):1139-44. PubMed ID: 25192832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Testing of vaccines. The challenge of testing complex combination vaccines].
    Merkle A; Lechner H; Oppling V; Meyer H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Oct; 57(10):1188-92. PubMed ID: 25204275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Testing of medicinal products produced from pooled plasma].
    Unkelbach U; Hunfeld A; Breitner-Ruddock S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Oct; 57(10):1181-4. PubMed ID: 25213735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Official testing of immunological veterinary medicinal products].
    Jungbäck C; Motitschke A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Oct; 57(10):1193-7. PubMed ID: 25168840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent control of COVID-19 vaccines by EU Official Control Authority Batch Release: challenges, strengths and successes.
    Milne C; Wagner R; Cano F; Bruysters M; Waeterloos G; Pullirsch D; Wierer M; Mallet L
    NPJ Vaccines; 2023 Feb; 8(1):22. PubMed ID: 36823287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality Control of Immunological Veterinary Medicinal Products in Europe.
    Pasik K; Łysiak E
    J Vet Res; 2019 Dec; 63(4):587-595. PubMed ID: 31934671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of product batches (before and after registration). The German approach.
    Jungbäck C
    Dev Biol Stand; 1992; 79():171-4. PubMed ID: 1286753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Batch testing as an essential pillar of the supply of safe and effective vaccines].
    Sediri-Schön H; Lange J; Grabski E; Wagner R; Hildt E
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2022 Dec; 65(12):1244-1250. PubMed ID: 36264321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calibration of the Ph. Eur. Biological Reference Preparation (BRP) for tetanus vaccine (adsorbed) batch 3.
    Tierney R; Hockley J; Rigsby P; Terao E; Daas A; Buchheit KH; Sesardic D
    Pharmeur Bio Sci Notes; 2011 Jun; 2011(1):1-26. PubMed ID: 21619853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The target animal safety test--is it still relevant?
    Advisory Group on Alternatives to Animal Testing in Immunobiologicals
    Biologicals; 2002 Dec; 30(4):277-87. PubMed ID: 12474863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Batch release of immunoglobulin and monoclonal antibody products].
    Gross S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Oct; 57(10):1185-7. PubMed ID: 25200488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality control of seasonal influenza vaccines.
    Mandušić Nazor T; Pipić Kosanović M; Tomić S
    Arh Hig Rada Toksikol; 2010 Dec; 61(4):437-43. PubMed ID: 21183435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Descriptive investigation of the recording of influenza vaccination details on The Health Information Network database.
    Hall GC; Hill F
    Pharmacoepidemiol Drug Saf; 2014 Jun; 23(6):595-600. PubMed ID: 24123471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interpretation of size-exclusion chromatography for the determination of molecular-size distribution of human immunoglobulins.
    Christians S; Schluender S; van Treel ND; Behr-Gross ME
    Pharmeur Bio Sci Notes; 2016; 2016():115-28. PubMed ID: 27593533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [European Network of Official Medicines Control Laboratories : International OMCL Working Group Combating Counterfeit and other Illegal Medicines].
    Wanko R; Unkelbach U
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1221-1227. PubMed ID: 28921172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing the reproducibility of serological methods used to evaluate immunogenicity of pandemic H1N1 influenza vaccines-an effective EU regulatory approach.
    Wagner R; Göpfert C; Hammann J; Neumann B; Wood J; Newman R; Wallis C; Alex N; Pfleiderer M
    Vaccine; 2012 Jun; 30(27):4113-22. PubMed ID: 22446639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of product batches (before and after registration). The Belgian approach.
    Pensaert M
    Dev Biol Stand; 1992; 79():183-6. PubMed ID: 1286756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Licensing and control authority batch release of influenza vaccine in Germany in accordance with EEC regulations.
    Weeke-Lüttmann M
    Eur J Epidemiol; 1994 Aug; 10(4):513-4. PubMed ID: 7843372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanics and effects of European reference pricing for vaccines in Germany according to §130a Abs. 2 SGB V: an analysis using the example of influenza vaccines].
    Barth J; Hammerschmidt T; Vollmar J; Bierbaum M; Schöffski O
    Gesundheitswesen; 2014 Apr; 76(4):e7-e13. PubMed ID: 24081570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.